What question did this study set out to answer?

To evaluate the published technical and clinical validation evidence for regulatory-approved commercial automated volumetric MRI tools against the Quantitative Neuroradiology Initiative framework.

September 3, 2021NeuroradiologyOpen Access

Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review

View Full Paper

Ask AI

Bookmark

Authors

HPHugh PembertonAmersham Hospital LZLara A. M. ZakiErasmus MC OGOlivia GoodkinQueen Mary University of London

Discussion

Member takes

Implication

Systematic review reveals sparse clinical validation for commercial volumetric MRI tools in dementia diagnosis, highlighting critical evidence gaps before routine clinical adoption.

Key Points

To evaluate the published technical and clinical validation evidence for regulatory-approved commercial automated volumetric MRI tools against the Quantitative Neuroradiology Initiative framework.
Systematically reviewed published literature on regulatory-approved commercial automated volumetric MRI reporting tools (QReports) intended for memory clinic workflows.
Assessed identified products against the six development, validation, and clinical integration steps outlined by the Quantitative Neuroradiology Initiative (QNI) framework.
Identified 17 commercial automated volumetric MRI tools, of which 11 vendor companies published technical validation of their analytical methods.
Only 4 of the 17 identified commercial products had published clinical validation evaluating their quantitative reports specifically in a dementia patient cohort.
Identified widespread evidence deficits regarding real-world clinical workflow integration and prospective in-use performance evaluation for dementia diagnosis.

Cite This Study

Pemberton et al. (2021) studied this question.

synapsesocial.com/papers/69d76d4cdb9d5e1bf4b8a615 https://doi.org/10.1007/s00234-021-02746-3

View Full Paper

Ask AI

Bookmark

Implication

Systematic review reveals sparse clinical validation for commercial volumetric MRI tools in dementia diagnosis, highlighting critical evidence gaps before routine clinical adoption.

Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review

Discussion

Member takes

Implication

Key Points

Cite This Study

Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider